Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative.
Bilgrami ZR, Castro E, Agurto C, Liebenthal E, Ennis M, Baker JT, Scott I, Colton BL, Cho KIK, Li L, Tamayo Z, Henecks M, Rahimi Eichi H, Henry T, Addington J, Alameda LK, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Calkins ME, Chen EYH, Choi J, Conus P, Cornblatt BA, Ellman LM, Fusar-Poli P, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui C, Kambeitz J, Kambeitz-Ilankovic L, Keshavan MS, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Mamah D, Diaz-Caneja CM, Mathalon DH, Mittal VA, Nordentoft M, Pearlson GD, Perez J, Perkins DO, Powers AR 3rd, Rogers J, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Stone WS, Yassin W, Strauss GP, Thompson JL, Upthegrove R, Verma S, Wang J, Wolf DH, McGorry PD, Kahn RS, Kane JM, Anticevic A, Bearden CE, Dwyer D, Billah T, Bouix S, Pasternak O, Shenton ME, Woods SW, Nelson B; Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ); Cecchi GA, Corcoran CM, Wolff PM. Bilgrami ZR, et al. Among authors: langbein k. Schizophrenia (Heidelb). 2025 Oct 15;11(1):125. doi: 10.1038/s41537-025-00669-z. Schizophrenia (Heidelb). 2025. PMID: 41093845 Free PMC article.
Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program.
Addington J, Liu L, Chu M, Jungert K, Penzel N, Pasternak O, Farina E, Carrion RE, Corcoran CM, Mittal VA, Strauss GP, Yung AR, Alameda L, Arango C, Borders O, Bouix S, Breitborde NJK, Broome MR, Cadenhead KS, Castillo-Passi RI, Chen EYH, Choi J, Coleman MJ, Conus P, Diaz-Caneja CM, Ellman LM, Poli PF, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Kapur T, Kelly S, Kerr MJ, Keshavan MS, Kim M, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Lewandowski KE, Mamah D, Marcy PJ, Mathalon DH, Mourgues C, Nordentoft M, Nunez AR, Pearlson GD, Perez J, Perkins DO, Powers AR 3rd, Rogers J, Sabb FW, Schiffman J, Seitz-Holland J, Shah JL, Silverstein SM, Smesny S, Stone WS, Thompson JL, Upthegrove R, Verma S, Wang J, Wolf DH, Zhang T, Addamo L, Buccilli K, Dwyer D, Todd S, Cho YT, Fontenau C, Tamayo Z, Bearden CE, Kane JM, McGorry PD, Kahn RS, Shenton ME, Woods SW; Accelerating Medicines Partnership® Schizophrenia Nelson Barnaby; Calkins ME. Addington J, et al. Among authors: langbein k. Schizophr Bull Open. 2025 Aug 25;6(1):sgaf012. doi: 10.1093/schizbullopen/sgaf012. eCollection 2025 Jan. Schizophr Bull Open. 2025. PMID: 40861307 Free PMC article.
Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program.
Addington J, Shalev A, Liu L, Jahraus C, Chu M, Farina E, Fusar Poli P, Marcy PJ, Nunez AR, Calkins ME, Alameda L, Arango C, Borders O, Bouix S, Breitborde NJK, Broome MR, Cadenhead KS, Carrion RE, Castillo-Passi RI, Chen EYH, Choi J, Coleman MJ, Conus P, Corcoran CM, Diaz-Caneja CM, Ellman LM, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Kapur T, Kelly S, Kerr MJ, Keshavan MS, Kim M, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Lewandowski KE, Mamah D, Mathalon DH, Mittal VA, Mourgues C, Nordentoft M, Pasternak O, Pearlson GD, Penzel N, Perez J, Perkins DO, Powers AR 3rd, Rogers J, Sabb FW, Schiffman J, Seitz-Holland J, Shah JL, Silverstein SM, Smesny S, Stone WS, Strauss GP, Thompson JL, Upthegrove R, Verma S, Wang J, Wolf DH, Yung AR, Zhang T, Addamo L, Buccilli K, Todd S, Dwyer D, Bearden CE, Kane JM, McGorry PD, Kahn RS, Shenton ME, Woods SW; Accelerating Medicines Partnership® Schizophrenia Nelson Barnaby. Addington J, et al. Among authors: langbein k. Schizophr Bull Open. 2025 Aug 25;6(1):sgaf013. doi: 10.1093/schizbullopen/sgaf013. eCollection 2025 Jan. Schizophr Bull Open. 2025. PMID: 40861306 Free PMC article.
The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures.
Mathalon DH, Nicholas S, Roach BJ, Billah T, Lavoie S, Whitford T, Hamilton HK, Addamo L, Anohkin A, Bekinschtein T, Belger A, Buccilli K, Cahill J, Carrión RE, Damiani S, Dzafic I, Ebdrup BH, Izyurov I, Jarcho J, Jenni R, Jo A, Kerins S, Lee C, Martin EA, Mayol-Troncoso R, Niznikiewicz MA, Parvaz M, Pogarell O, Prieto-Montalvo J, Rabin R, Roalf DR, Rogers J, Salisbury DF, Shaik R, Shankman S, Stevens MC, Suen YN, Swann NC, Tang X, Thompson JL, Tso I, Wenzel J, Zhou JH, Addington J, Alameda L, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Calkins ME, Castillo-Passi RI, Chen EYH, Choi J, Conus P, Corcoran CM, Cornblatt BA, Diaz-Caneja CM, Ellman LM, Fusar-Poli P, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Keshavan MS, Kim M, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Mamah D, Mittal VA, Nordentoft M, Pearlson GD, Perez J, Perkins DO, Powers AR, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Stone WS, Strauss GP, Upthegrove R, Verma SK, Wang J, Wolf DH, Zhang T, Bouix S, Pasternak O, Cho KK, Coleman MJ, Dwyer D, Nunez A, Tamayo Z, Wood SJ, Kahn RS, Kane JM, McGorry PD, Bearden CE, Nelson B, Woods SW, Shenton ME; Ac… See abstract for full author list ➔ Mathalon DH, et al. Among authors: langbein k. Schizophrenia (Heidelb). 2025 Jun 6;11(1):85. doi: 10.1038/s41537-025-00622-0. Schizophrenia (Heidelb). 2025. PMID: 40480970 Free PMC article.
Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program.
Wigman JTW, Ching AE, Chung Y, Eichi HR, Lane E, Langholm C, Vaidyam A, Byun AJS, Haidar A, Hartmann J, Nunez A, Dwyer D, Nasarudin AA, Borders O, Scott I, Tamayo Z, Matneja P, Cho KI, Addington J, Alameda LK, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Calkins ME, Chen EYH, Choi J, Conus P, Corcoran CM, Cornblatt BA, Diaz-Caneja CM, Ellman LM, Fusar-Poli P, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Keshavan MS, Kim SW, Koutsouleris N, Langbein K, Mamah D, Mathalon DH, Mittal VA, Nordentoft M, Pearlson GD, Perez J, Perkins DO, Powers AR 3rd, Rogers J, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Yassin W, Stone WS, Strauss GP, Thompson JL, Upthegrove R, Verma S, Wang J, Wolf DH, Wolff P; Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ); Rowland LM, D'Alfonso S, Pasternak O, Bouix S, McGorry PD, Kahn RS, Kane JM, Bearden CE, Woods SW, Shenton ME, Nelson B, Baker JT, Torous J. Wigman JTW, et al. Among authors: langbein k. Schizophrenia (Heidelb). 2025 Jun 3;11(1):83. doi: 10.1038/s41537-025-00599-w. Schizophrenia (Heidelb). 2025. PMID: 40461469 Free PMC article.
Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program.
Addington J, Liu L, Braun A, Auther A, Calkins ME, Cornblatt BA, Corcoran CM, Fusar-Poli P, Kerr MJ, Mourgues-Codern CV, Nunez AR, Oliver D, Strauss GP, Walsh BC, Alameda LK, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Carrion RE, Chen EYH, Choi J, Coleman MJ, Conus P, Diaz-Caneja CM, Dwyer D, Ellman LM, Faghankhani M, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui C, Jacobs GR, Kambeitz J, Kambeitz-Ilankovic L, Keshavan MS, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Lewandowski KE, Mamah D, Marcy PJ, Mathalon DH, Mittal VA, Nordentoft M, Pearlson GD, Penzel N, Perez J, Perkins DO, Powers AR 3rd, Rogers J, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Stone WS, Thompson A, Thompson JL, Upthegrove R, Verma S, Wang J, Wastler HM, Wickham A, Rossum IW, Wolf DH, Bouix S, Pasternak O, Kahn RS, Bearden CE, Kane JM, McGorry PD, Buccilli K, Nelson B, Shenton ME, Woods SW; Accelerating Medicines Partnership® -Schizophrenia; Yung AR. Addington J, et al. Among authors: langbein k. Schizophrenia (Heidelb). 2025 Apr 3;11(1):54. doi: 10.1038/s41537-025-00556-7. Schizophrenia (Heidelb). 2025. PMID: 40180953 Free PMC article.
The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program.
Harms MP, Cho KK, Anticevic A, Bolo NR, Bouix S, Campbell D, Cannon TD, Cecchi G, Goncalves M, Haidar A, Hughes DE, Izyurov I, John O, Kapur T, Kim N, Kotler E, Kubicki M, Kuperman JM, Laulette K, Lindberg U, Markiewicz C, Ning L, Poldrack RA, Rathi Y, Romo PA 3rd, Tamayo Z, Wannan C, Wickham A, Yassin W, Zhou JH, Addington J, Alameda L, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Calkins ME, Chen EYH, Choi J, Conus P, Corcoran CM, Cornblatt BA, Diaz-Caneja CM, Ellman LM, Fusar-Poli P, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Keshavan MS, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Mamah D, Mathalon DH, Mittal VA, Nordentoft M, Pearlson GD, Perez J, Perkins DO, Powers AR 3rd, Rogers J, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Stone WS, Strauss GP, Thompson JL, Upthegrove R, Verma SK, Wang J, Wolf DH, Kahn RS, Kane JM, McGorry PD, Nelson B, Woods SW, Shenton ME, Wood SJ, Bearden CE; Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ); Pasternak O. Harms MP, et al. Among authors: langbein k. Schizophrenia (Heidelb). 2025 Apr 2;11(1):52. doi: 10.1038/s41537-025-00581-6. Schizophrenia (Heidelb). 2025. PMID: 40175382 Free PMC article.
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample.
Allott K, Yassin W, Alameda L, Billah T, Borders O, Buccilli K, Carrión RE, Castillo-Passi RI, Cho KIK, Chin K, Coleman MJ, Colton BL, Corral S, Dwyer D, Gundersen KB, Gur RC, Hoftman GD, Jacobs GR, Kelly S, Lewandowski KE, Marcy PJ, Matneja P, McLaughlin D, Nunez AR, Parsa S, Penzel N, Ray S, Reinen JM, Ruparel K, Sand MS, Santorelli G, Seitz-Holland J, Spark J, Tamayo Z, Thompson A, Tod S, Wannan CMJ, Wickham A, Wood SJ, Zoupou E, Addington J, Anticevic A, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Calkins ME, Chen EYH, Choi J, Conus P, Corcoran CM, Cornblatt BA, Ellman LM, Fusar-Poli P, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Keshavan M, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Mamah D, Diaz-Caneja CM, Mathalon DH, Mittal VA, Nordentoft M, Pearlson GD, Perkins DO, Perez J, Powers AR 3rd, Rogers J, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Strauss GP, Thompson JL, Upthegrove R, Verma SK, Wang J, Wolf DH, Pasternak O, Bouix S, McGorry PD, Kane JM, Kahn RS, Bearden CE, Shenton ME, Woods SW, Nelson B; Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ); Stone WS. Allott K, et al. Among authors: langbein k. Schizophrenia (Heidelb). 2025 Mar 24;11(1):49. doi: 10.1038/s41537-025-00578-1. Schizophrenia (Heidelb). 2025. PMID: 40128256 Free PMC article.
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis.
Wannan CMJ, Nelson B, Addington J, Allott K, Anticevic A, Arango C, Baker JT, Bearden CE, Billah T, Bouix S, Broome MR, Buccilli K, Cadenhead KS, Calkins ME, Cannon TD, Cecci G, Chen EYH, Cho KIK, Choi J, Clark SR, Coleman MJ, Conus P, Corcoran CM, Cornblatt BA, Diaz-Caneja CM, Dwyer D, Ebdrup BH, Ellman LM, Fusar-Poli P, Galindo L, Gaspar PA, Gerber C, Glenthøj LB, Glynn R, Harms MP, Horton LE, Kahn RS, Kambeitz J, Kambeitz-Ilankovic L, Kane JM, Kapur T, Keshavan MS, Kim SW, Koutsouleris N, Kubicki M, Kwon JS, Langbein K, Lewandowski KE, Light GA, Mamah D, Marcy PJ, Mathalon DH, McGorry PD, Mittal VA, Nordentoft M, Nunez A, Pasternak O, Pearlson GD, Perez J, Perkins DO, Powers AR 3rd, Roalf DR, Sabb FW, Schiffman J, Shah JL, Smesny S, Spark J, Stone WS, Strauss GP, Tamayo Z, Torous J, Upthegrove R, Vangel M, Verma S, Wang J, Rossum IW, Wolf DH, Wolff P, Wood SJ, Yung AR, Agurto C, Alvarez-Jimenez M, Amminger P, Armando M, Asgari-Targhi A, Cahill J, Carrión RE, Castro E, Cetin-Karayumak S, Mallar Chakravarty M, Cho YT, Cotter D, D'Alfonso S, Ennis M, Fadnavis S, Fonteneau C, Gao C, Gupta T, Gur RE, Gur RC, Hamilton HK, Hoftman GD, Jacobs GR, Jarcho J, Ji JL, Kohler CG, Lalo… See abstract for full author list ➔ Wannan CMJ, et al. Among authors: langbein k. Schizophr Bull. 2024 Apr 30;50(3):496-512. doi: 10.1093/schbul/sbae011. Schizophr Bull. 2024. PMID: 38451304 Free PMC article.
41 results